Showing results (931-940 of 945) with videos related to
Sort By:
Pageof 95
Journal of Clinical Pharmacology|June 6, 2008
PhRMA white paper on ADME pharmacogenomicsJ Andrew Williams, Tommy Andersson, Tommy B Andersson, et al.Cytotherapy|April 30, 2010
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipientsJ L Gajewski, S Nimer, R M Saliba, et al.Rheumatology (Oxford, England)|August 1, 2006
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort studyR Gutiérrez-Suárez, A Pistorio, A Cespedes Cruz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantationJ Gajewski, D Gjertson, M Cecka, et al.Asia Pacific Journal of Clinical Nutrition|January 8, 2014
Hormones, body composition and cardiovascular riskL Sjöström, M Alpsten, B Andersson, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2001
An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalantT B Andersson, H Sjöberg, K J Hoffmann, et al.Leukemia & Lymphoma|March 8, 2000
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphomaM L Donato, R E Champlin, K W Van Besien, et al.Journal of the National Cancer Institute|February 3, 2000
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinomaG N Hortobagyi, A U Buzdar, R L Theriault, et al.Journal of Human Hypertension|September 27, 2013
Blood pressure changes after renal denervation at 10 European expert centersA Persu, Y Jin, M Azizi, et al.The Pharmacogenomics Journal|May 17, 2007
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesisA Kindmark, A Jawaid, C G Harbron, et al.Pageof 95